MedTrace Logo

Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin

NCT02675335 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2016-09-15

No results posted yet for this study

Summary

The purpose of the study is to test the effect of Sitagliptin on the healing of stable, nonhealing diabetic foot ulcers. This is a randomized placebo-controlled Trial.

Conditions

  • Diabetic Foot

Interventions

DRUG

Sitagliptin

DRUG

Placebo

Sponsors & Collaborators

  • Wolfgang-Michael Franz

    lead OTHER

Principal Investigators

  • Wolfgang-M Franz, M.D. · Medical University of Innsbruck

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-03-31
Completion
2018-03-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02675335 on ClinicalTrials.gov